김효석 (한국과학기술연구원(KIST))님 | 한빛사연구자 > 한빛사

한국과학기술연구원(KIST)

최종업데이트 2022.08.10.

Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer
- Bioact. Mater., Volume 25, July 2023 | https://doi.org/10.1016/j.bioactmat.2022.07.021
- 2023-07
- 바이오·의료융합
- 한빛사논문
Extracellular vesicle-guided in situ reprogramming of synovial macrophages for the treatment of rheumatoid arthritis
- Biomaterials, Volume 286, July 2022, 121578 | https://doi.org/10.1016/j.biomaterials.2022.121578
- 2022-07
- 바이오·의료융합
- 한빛사논문
Ultraefficient extracellular vesicle–guided direct reprogramming of fibroblasts into functional cardiomyocytes
- Sci. Adv., 25 Feb 2022 • Vol 8, Issue 8 |10.1126/sciadv.abj6621
- 2022-02
- 바이오·의료융합
- 한빛사논문
A Trojan-Horse Strategy by In Situ Piggybacking onto Endogenous Albumin for Tumor-Specific Neutralization of Oncogenic MicroRNA
- ACS Nano, Publication Date:June 30, 2021 | https://doi.org/10.1021/acsnano.1c00799
- 2021-06
- 바이오·의료융합
- 한빛사논문
Exosome‐Guided Phenotypic Switch of M1 to M2 Macrophages for Cutaneous Wound Healing
- Adv. Sci., First published: 27 August 2019 | https://doi.org/10.1002/advs.201900513
- 2019-08
- 바이오·의료융합
- 한빛사논문

연구자 ID

저자논문